Journal of Addiction Research(JAR)

Alcohol Addiction Treatment

Three medications are approved by the U.S. Food and Drug Administration to treat alcohol use disorder: acamprosate, disulfiram, and naltrexone. Acamprosate and naltrexone reduce alcohol consumption and increase abstinence rates, although the effects appear to be modest.

Journal key Highlights

Abnormal Psychology Addiction Addiction Psychiatry Addiction Recovery Addictive Drug Adolescent Addiction Adolescent Anxiety Alcohol Abuse Alcohol Addiction Treatment Alcohol Drinking Alcohol Rehabilitation Alcoholism Alzheimers Symptoms Amphetamine Addiction Analytical Psychology Anxiety Disorders Autism Behavioral Addiction Biochemical Metabolism Biological Psychiatry Bipolar Psychosis Brain Disorders Caffeine Cocaine Addiction Cognitive Disorders Community Psychiatry Comorbidity Cytochrome 450 Drug Metabolism Depression Disorders Drug Dependence Drug Rehabilitation Drug Therapy Drug Tolerance Drug Use Disorders Gambling Health Consequences of Drug Misuse Hepatitis (Viral) Heroin Addiction Treatment Illegal Drugs Insomnia Legal Drugs Mental and Behavioral Disorders Morphine Addiction Narcotics Neurocognitive Disorders Neuropsychological Disorder Nicotine Opioid Overdose Reversal with Naloxone (Narcan, Evzio) Opioid-Related Disorders Post Traumatic Disorders Prevention Recovery Smoking Study of Addiction Substance Abuse in Military Life Substance Use and SUDs in LGBT Populations Substance-Related Disorders Tobacco Use Disorder Trauma Traumatic Stress Treatment Veterinary Epidemiology Women and Drugs Yoga psychotherapy